SCHEMBL100978

SCHEMBL100978

CCOCCCC(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene Glycol SCHEMBL28725543 0.93 ALDH1A1 (0.48)
SCHEMBL31607435 0.93 CES2 (0.48)
SCHEMBL1921248 0.87 ALDH1A1 (0.50)
Ethylene Glycol SCHEMBL28725533 0.87 ALDH1A1 (0.46)
Ethylene Glycol SCHEMBL28725531 0.85 CES2 (0.47)
SCHEMBL26838518 0.84 ALDH1A1 (0.42)
SCHEMBL18660230 0.84 ALDH1A1 (0.47)
SCHEMBL101044 0.84
SCHEMBL18996625 0.83 CES2 (0.54)
SCHEMBL8016543 0.83 CES2 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118354781-A Peptide inhibitors of interleukin-23 receptor 西兰制药公司 2024-07-16 CN disclosed
US-9920365-B2 Functionalized cyanine dyes (PEG) PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2018-03-20 US disclosed
WO-2017059411-A9 INHIBITORS OF MENAQUINONE BIOSYNTHESIS MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2017-08-31 WO disclosed
US-20170136104-A1 GLYCOPEGYLATED FACTOR IX NOVO NORDISK AS (DK) 2017-05-18 US disclosed
WO-2017041139-A1 LYMPH DIRECTING PRODRUGS MONASH UNIVERSITY (AU) 2017-03-16 WO disclosed
US-20160361427-A1 Glycopegylated Factor IX NOVO NORDISK AS (DK) 2016-12-15 US disclosed
US-20160184412-A1 Glycopegylated Factor IX NOVO NORDISK AS (DK) 2016-06-30 US disclosed
US-20160158319-A1 REMODELING AND GLYCOPEGYLATION OF FIBROBLAST GROWTH FACTOR (FGF) NOVO NORDISK A/S (DK) 2016-06-09 US disclosed
US-20150344950-A1 Functionalized Cyanine Dyes (PEG) PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2015-12-03 US disclosed
US-9200049-B2 Remodeling and glycopegylation of fibroblast growth factor (FGF) NOVO NORDISK A/S (DK) 2015-12-01 US disclosed
US-20080176790-A1 Remodeling and Glycopegylation of Fibroblast Growth Factor (Fgf) 89BIO, INC. 2008-07-24 US disclosed
US-5512577-A Bicyclic hexahydroaporphine and 1-benzyloctahydroisoquinoline therapeutic compositions and processes for utilizing said compositions CREIGHTON UNIVERSITY (US) 1996-04-30 US disclosed
EP-0666855-A1 4-QUINOLINYL DERIVATIVES WITH ANTI-HELICOBACTER ACTIVITY. JANSSEN PHARMACEUTICA NV (BE) 1995-08-16 EP disclosed
WO-1994010164-A1 4-QUINOLINYL DERIVATIVES WITH ANTI-HELICOBACTER ACTIVITY JANSSEN PHARMACEUTICA N.V. (BE) 1994-05-11 WO disclosed
US-4443475-A ANTIARRHYTHMIA AGENTS, ANTIDEPRESSANTS CAVAZZA CLAUDIO (IT) 1984-04-17 US disclosed
US-4234619-A Decholesterolized and defatted egg powder and method for producing same ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1980-11-18 US disclosed
US-4153778-A POLYOXYBUTYLENE GLYCOL OR POLYCAPROLACTONE CAPPED WITH A DIISOCYANATE, A DI- OR TRI-METHYLOL CARBOXYLIC ACID, AND A HYDROXY-ALKYL ACR UNION CARBIDE CORPORATION (US) 1979-05-08 US disclosed
US-3978134-A INSECTICIDE SANDOZ LTD. (CH) 1976-08-31 US disclosed
US-3968235-A Composition and method for combating insects with alkylenedioxyphenyl derivatives SANDOZ LTD. (CH) 1976-07-06 US disclosed
US-3933804-A Insecticidal 1,3-benzodioxol derivatives SANDOZ LTD., (SANDOZ AG) (CH) 1976-01-20 US disclosed